Search

everythinglearnresearchcommunity

for

Search:↓

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Medulla loss in scalp hair could help detect breast cancer.

A specific gene variation is linked to a higher risk of polycystic ovary syndrome in Caucasian women.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

There is no significant link between the MMP-1 rs1799750 polymorphism and androgenetic alopecia in the Indonesian population.

Mutations in the SNRPE gene cause hereditary hair loss.

The scraggly mutation causes hair loss and skin defects in mice.

Modified β-catenin causes different effects in hair and skin cells, leading to cysts or tumors.

A new mutation in mice causes crooked whiskers and messy hair.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

VHL disease can cause early paragangliomas, needing lifelong monitoring.

A Taiwanese patient had hair loss and skin bumps without the usual gene mutation, suggesting other genetic factors might be involved.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

LRIG1 is linked to better survival in Merkel cell carcinoma.

Methylated gene parts may cause finasteride-resistance in some enlarged prostate patients.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

A new mutation in the hairless gene causes hair loss and skin wrinkling in mice.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

Keratin mutations may cause scarring alopecia by damaging hair structure.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Severe CCCA may be biologically and clinically different from milder forms.

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

Androgen receptor overexpression can increase prostate cancer cell growth even without hormones.